The sodium pump (Na+/K + -ATPase) presents a promising avenue for the advancement of anticancer pharmaceuticals due to its role as a signaling mediator, involvement in cell adhesion, and its association with aberrant expression and activity, which are linked to the onset and advancement of various cancer types. Here, ATP12A is linked to cancer.